FireCyte Therapeutics
Cambridge, US · Founded 2021 · Delaware corporation
Founders & leadership
RH
Ruoxi HuNamed on SEC filing
WE
William E YelleNamed on SEC filing
CK
Charles KunschNamed on SEC filing
Board
MF
Meredith FisherBoard director
Reported raises · per SEC filings
Form D private placements$5.5M disclosed across 1 round · 2022
▶$5.5MraisedFeb 2022 · 3 investors · OtherRule 506(b)
▶$5.5MraisedFeb 2022 · 3 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Meredith FisherDirector
- Ruoxi HuDirector
- William E YelleExecutive Officer, Director
- Charles KunschDirector
- Offering amount
- $12M
- Amount sold
- $5.5M
- First sale
- Jan 2022
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has FireCyte Therapeutics raised?
- FireCyte Therapeutics has disclosed $5.5M raised across 1 round.
- Where is FireCyte Therapeutics headquartered?
- FireCyte Therapeutics is headquartered in Cambridge, US.